Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | SARS-CoV-2 | Research article

Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark

Authors: Kamille Fogh, Alexandra R. R. Eriksen, Rasmus B. Hasselbalch, Emilie Sofie Kristensen, Henning Bundgaard, Susanne D. Nielsen, Charlotte S. Jørgensen, Bibi F. S. S. Scharff, Christian Erikstrup, Susanne G. Sækmose, Dorte K. Holm, Bitten Aagaard, Jakob Norsk, Pernille Brok Nielsen, Jonas H. Kristensen, Lars Østergaard, Svend Ellermann-Eriksen, Berit Andersen, Henrik Nielsen, Isik S. Johansen, Lothar Wiese, Lone Simonsen, Thea K. Fischer, Fredrik Folke, Freddy Lippert, Sisse R. Ostrowski, Steen Ethelberg, Anders Koch, Anne-Marie Vangsted, Tyra Grove Krause, Anders Fomsgaard, Claus Nielsen, Henrik Ullum, Robert Skov, Kasper Iversen

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

COVID-19 is thought to be more prevalent among ethnic minorities and individuals with low socioeconomic status. We aimed to investigate the prevalence of SARS-CoV-2 antibodies during the COVID-19 pandemic among citizens 15 years or older in Denmark living in social housing (SH) areas.

Methods

We conducted a study between January 8th and January 31st, 2021 with recruitment in 13 selected SH areas. Participants were offered a point-of-care rapid SARS-CoV-2 IgM and IgG antibody test and a questionnaire concerning risk factors associated with COVID-19. As a proxy for the general Danish population we accessed data on seroprevalence from Danish blood donors (total Ig ELISA assay) in same time period.

Results

Of the 13,279 included participants, 2296 (17.3%) were seropositive (mean age 46.6 (SD 16.4) years, 54.2% female), which was 3 times higher than in the general Danish population (mean age 41.7 (SD 14.1) years, 48.5% female) in the same period (5.8%, risk ratios (RR) 2.96, 95% CI 2.78–3.16, p > 0.001). Seropositivity was higher among males (RR 1.1, 95% CI 1.05–1.22%, p = 0.001) and increased with age, with an OR seropositivity of 1.03 for each 10-year increase in age (95% CI 1.00–1.06, p = 0.031). Close contact with COVID-19-infected individuals was associated with a higher risk of infection, especially among household members (OR 5.0, 95% CI 4.1–6.2 p < 0,001). Living at least four people in a household significantly increased the OR of seropositivity (OR 1.3, 95% CI 1.0–1.6, p = 0.02) as did living in a multi-generational household (OR 1.3 per generation, 95% CI 1.1–1.6, p = 0.003). Only 1.6% of participants reported not following any of the national COVID-19 recommendations.

Conclusions

Danish citizens living in SH areas of low socioeconomic status had a three times higher SARS-CoV-2 seroprevalence compared to the general Danish population. The seroprevalence was significantly higher in males and increased slightly with age. Living in multiple generations households or in households of more than four persons was a strong risk factor for being seropositive. Results of this study can be used for future consideration of the need for preventive measures in the populations living in SH areas.
Appendix
Available only for authorised users
Literature
2.
go back to reference Goujon A, Natale F, Ghio D, Conte A, Dijkstra L. Age, gender, and territory of COVID-19 infections and fatalities. Luxembourg: Publications Office of the European Union; 2020. Goujon A, Natale F, Ghio D, Conte A, Dijkstra L. Age, gender, and territory of COVID-19 infections and fatalities. Luxembourg: Publications Office of the European Union; 2020.
4.
go back to reference Sze S, Pan D, Nevill CR, Gray LJ, Martin CA, Nazareth J, et al. Ethnicity and clinical outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2020;29:100630.CrossRef Sze S, Pan D, Nevill CR, Gray LJ, Martin CA, Nazareth J, et al. Ethnicity and clinical outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2020;29:100630.CrossRef
5.
go back to reference Consolazio D, Murtas R, Tunesi S, Gervasi F, Benassi D, Russo AG. Assessing the impact of individual characteristics and neighborhood socioeconomic status during the COVID-19 pandemic in the provinces of Milan and Lodi. Int J Health Serv. 2021;51:311–24.CrossRef Consolazio D, Murtas R, Tunesi S, Gervasi F, Benassi D, Russo AG. Assessing the impact of individual characteristics and neighborhood socioeconomic status during the COVID-19 pandemic in the provinces of Milan and Lodi. Int J Health Serv. 2021;51:311–24.CrossRef
6.
go back to reference Rostila M, Cederstrom A, Wallace M, Branden M, Malmberg B, Andersson G. Disparities in COVID-19 deaths by country of birth in Stockholm, Sweden: a total population based cohort study. Am J Epidemiol. 2021;190:1510–8.CrossRef Rostila M, Cederstrom A, Wallace M, Branden M, Malmberg B, Andersson G. Disparities in COVID-19 deaths by country of birth in Stockholm, Sweden: a total population based cohort study. Am J Epidemiol. 2021;190:1510–8.CrossRef
10.
go back to reference Greenaway C, Hargreaves S, Barkati S, Coyle CM, Gobbi F, Veizis A, et al. COVID-19: exposing and addressing health disparities among ethnic minorities and migrants. J Travel Med. 2020;27(7):taa113.CrossRef Greenaway C, Hargreaves S, Barkati S, Coyle CM, Gobbi F, Veizis A, et al. COVID-19: exposing and addressing health disparities among ethnic minorities and migrants. J Travel Med. 2020;27(7):taa113.CrossRef
11.
go back to reference Erikstrup C, Hother CE, Pedersen OBV, Molbak K, Skov RL, Holm DK, et al. Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors. Clin Infect Dis. 2021;72(2):249–53.CrossRef Erikstrup C, Hother CE, Pedersen OBV, Molbak K, Skov RL, Holm DK, et al. Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors. Clin Infect Dis. 2021;72(2):249–53.CrossRef
12.
go back to reference Madsen JR, Nielsen JPS, Fogh K, Hansen CB, Nielsen PB, Lange T, et al. Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen. medRxiv. 2021:2021.02.09.21251421. Madsen JR, Nielsen JPS, Fogh K, Hansen CB, Nielsen PB, Lange T, et al. Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen. medRxiv. 2021:2021.02.09.21251421.
13.
go back to reference Iversen K, Bundgaard H, Hasselbalch RB, Kristensen JH, Nielsen PB, Pries-Heje M, et al. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis. 2020;20(12):1401–8.CrossRef Iversen K, Bundgaard H, Hasselbalch RB, Kristensen JH, Nielsen PB, Pries-Heje M, et al. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis. 2020;20(12):1401–8.CrossRef
14.
go back to reference Espenhain L, Tribler S, Jørgensen CS, Holm Hansen C, Wolff Sönksen U, Ethelberg S. Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. medRxiv. 2021:2021.04.07.21254703. Espenhain L, Tribler S, Jørgensen CS, Holm Hansen C, Wolff Sönksen U, Ethelberg S. Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. medRxiv. 2021:2021.04.07.21254703.
16.
go back to reference Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.CrossRef Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.CrossRef
17.
go back to reference Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRef Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.CrossRef
19.
go back to reference Lassaunière R, Frische A, Sværke Jørgensen C. Evaluation of nine commercial SARS-CoV-2 immunoassays. medRxiv, preprint version. 2020. Lassaunière R, Frische A, Sværke Jørgensen C. Evaluation of nine commercial SARS-CoV-2 immunoassays. medRxiv, preprint version. 2020.
20.
go back to reference Harritshøj LH, Gybel-Brask M, Afzal S, Kamstrup PR, Jørgensen CS, Thomsen MK, et al. Comparison of 16 serological SARS-CoV-2 immunoassays in 16 clinical laboratories. J Clin Microbiol. 2021;59(5):e02596-20.CrossRef Harritshøj LH, Gybel-Brask M, Afzal S, Kamstrup PR, Jørgensen CS, Thomsen MK, et al. Comparison of 16 serological SARS-CoV-2 immunoassays in 16 clinical laboratories. J Clin Microbiol. 2021;59(5):e02596-20.CrossRef
22.
go back to reference Pedersen OB, Nissen J, Dinh KM, Schwinn M, Kaspersen KA, Boldsen JK, et al. SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors—a cross-sectional study. Clin Infect Dis. 2020;73:e2962–9.CrossRef Pedersen OB, Nissen J, Dinh KM, Schwinn M, Kaspersen KA, Boldsen JK, et al. SARS-CoV-2 infection fatality rate among elderly retired Danish blood donors—a cross-sectional study. Clin Infect Dis. 2020;73:e2962–9.CrossRef
23.
go back to reference Laursen J, Petersen J, Didriksen M, Iversen K, Ullum H. Prevalence of SARS-CoV-2 IgG/IgM antibodies among Danish and Swedish Falck emergency and non-emergency healthcare workers. Int J Environ Res Public Health. 2021;18(3):923.CrossRef Laursen J, Petersen J, Didriksen M, Iversen K, Ullum H. Prevalence of SARS-CoV-2 IgG/IgM antibodies among Danish and Swedish Falck emergency and non-emergency healthcare workers. Int J Environ Res Public Health. 2021;18(3):923.CrossRef
24.
go back to reference Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313–9.CrossRef Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396(10247):313–9.CrossRef
25.
go back to reference Roederer T, Mollo B, Vincent C, Nikolay B, Llosa AE, Nesbitt R, et al. Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study. Lancet Public Health. 2021;6(4):e202–9.CrossRef Roederer T, Mollo B, Vincent C, Nikolay B, Llosa AE, Nesbitt R, et al. Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study. Lancet Public Health. 2021;6(4):e202–9.CrossRef
26.
go back to reference Niedzwiedz CL, O’Donnell CA, Jani BD, Demou E, Ho FK, Celis-Morales C, et al. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Med. 2020;18(1):160.CrossRef Niedzwiedz CL, O’Donnell CA, Jani BD, Demou E, Ho FK, Celis-Morales C, et al. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Med. 2020;18(1):160.CrossRef
27.
go back to reference Lyngse FP, Kirkeby CT, Halasa T, Andreasen V, Skov RL, Møller FT, et al. COVID-19 transmission within danish households: a nationwide study from lockdown to reopening. medRxiv. 2020:2020.09.09.20191239. Lyngse FP, Kirkeby CT, Halasa T, Andreasen V, Skov RL, Møller FT, et al. COVID-19 transmission within danish households: a nationwide study from lockdown to reopening. medRxiv. 2020:2020.09.09.20191239.
28.
go back to reference Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ, Mansour M, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370(6521):1227–30.CrossRef Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ, Mansour M, et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science. 2020;370(6521):1227–30.CrossRef
Metadata
Title
Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark
Authors
Kamille Fogh
Alexandra R. R. Eriksen
Rasmus B. Hasselbalch
Emilie Sofie Kristensen
Henning Bundgaard
Susanne D. Nielsen
Charlotte S. Jørgensen
Bibi F. S. S. Scharff
Christian Erikstrup
Susanne G. Sækmose
Dorte K. Holm
Bitten Aagaard
Jakob Norsk
Pernille Brok Nielsen
Jonas H. Kristensen
Lars Østergaard
Svend Ellermann-Eriksen
Berit Andersen
Henrik Nielsen
Isik S. Johansen
Lothar Wiese
Lone Simonsen
Thea K. Fischer
Fredrik Folke
Freddy Lippert
Sisse R. Ostrowski
Steen Ethelberg
Anders Koch
Anne-Marie Vangsted
Tyra Grove Krause
Anders Fomsgaard
Claus Nielsen
Henrik Ullum
Robert Skov
Kasper Iversen
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07102-1

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue